Bicalutamide and Lacrimation increased - a phase IV clinical study of FDA data

Summary:

Lacrimation increased is reported as a side effect among people who take Bicalutamide (bicalutamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Calcium, and have Prostate cancer metastatic.

The phase IV clinical study analyzes which people have Lacrimation increased when taking Bicalutamide. It is created by eHealthMe based on reports of 9,859 people who have side effects when taking Bicalutamide from the FDA, and is updated regularly.

What is Bicalutamide?

Bicalutamide has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 9,930 Bicalutamide users. Check the latest studies of Bicalutamide.

What is Lacrimation increased?

Lacrimation increased is found to be associated with 1,342 drugs and 1,798 conditions by eHealthMe. Check the latest studies of Lacrimation increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

9,859 people reported to have side effects when taking Bicalutamide.
Among them, 57 people (0.58%) have Lacrimation increased.

Could Bicalutamide cause Lacrimation increased?

Among these 57 people:

How long have people been on Bicalutamide when they have Lacrimation increased? *

What is the gender of people who have Lacrimation increased when taking Bicalutamide? *

female: 0.0 %
male: 100 %

What is the age of people who have Lacrimation increased when taking Bicalutamide? *

What are other drugs people take besides Bicalutamide? *

Omnaris: 42 people, 73.68%
Calcium: 42 people, 73.68%
Advair Hfa: 39 people, 68.42%
Zoladex: 38 people, 66.67%
Fosamax: 36 people, 63.16%
Ventolin: 35 people, 61.40%
Calcium Disodium Versenate: 34 people, 59.65%
Methotrexate: 29 people, 50.88%
Ramipril: 29 people, 50.88%
Prednisone: 29 people, 50.88%

What are other side effects people have besides Lacrimation increased? *

Weight Loss: 51 people, 89.47%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 51 people, 89.47%
Asthma: 51 people, 89.47%
Atopy (a genetic disposition to develop an allergic reaction): 51 people, 89.47%
Blood Immunoglobulin E Increased: 51 people, 89.47%
Central Nervous System Mass: 51 people, 89.47%
Confusional State: 51 people, 89.47%
Eosinophil Count Increased: 51 people, 89.47%
Eosinophilic Myocarditis (acute and fulminate congestive heart failure): 51 people, 89.47%
Eosinophilic Pneumonia (eosinophil accumulates in the lung): 51 people, 89.47%

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 1 person, 1.75%

* Approximation only. Some reports may have incomplete information.

Do you take Bicalutamide and have Lacrimation increased?

- Check whether Lacrimation increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bicalutamide:

Bicalutamide (9,930 reports)

Browse all side effects of Bicalutamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lacrimation increased:

Lacrimation increased (1,342 drugs)

Browse all the conditions that are associated with Lacrimation increased:

Lacrimation increased (1,798 conditions)

Related publications that referenced our studies

Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .
Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on bicalutamide (the active ingredients of Bicalutamide) and Bicalutamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.